| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |